Skip to content
PaperFren

How might atropine slow experimental myopia?

Open paper intelligence

In form-deprived mice, atropine drops cut axial elongation and ECM remodeling, restored choroid/sclera thickness and CVI, lowered HIF-1α, and protected hypoxic scleral fibroblasts via P53/β-catenin pathways.

Source

The role of atropine in myopia control: insights into choroidal and scleral mechanisms

Huang L, Zhang J, Luo Y · Frontiers in pharmacology · 2025

doi.org/10.3389/fphar.2025.1509196Read the full paper ↗8 citationscc by

Study at a glance

Design
Animal / in-vitro — Form-deprivation myopia in C57BL/6 mice ± 10 mg/mL atropine drops TID; plus hypoxic MSF culture with Na2S2O4 then atropine
N
N=16 · N=4 mice per group × 4 groups (mock, atropine, FDM, FDM+atropine); in-vitro MSFs additional
Population
Male C57BL/6 mice (3 weeks) with monocular form deprivation and primary mouse scleral fibroblasts
Outcome
Axial length, ECM/collagen, choroid/sclera thickness, CVI, HIF-1α, and fibroblast signaling

Structured fields used in claim comparison tables when every cited study has a complete layer.

What they did

Covered one eye of 3-week C57BL/6 males (N=4/group) and gave saline or 10 mg/mL atropine TID for 21 days; measured ocular morphology, CVF, CVI, and ECM/HIF-1α. In vitro, MSFs were made hypoxic with Na2S2O4 then treated with atropine.

What they found

Atropine reduced FDM axial elongation and scleral collagen-volume-fraction remodeling, restored choroidal and scleral thickness, increased CVI (central/intermediate), reduced HIF-1α, and in vitro preserved fibroblast cytoskeleton while modulating P53 and β-catenin.

The limits

What it doesn't show

N=4/group is small; 10 mg/mL in mice is not the 0.01% pediatric drop used clinically, and human choroidal-flow causality is not proven here.

Key terms

Form deprivation myopia (FDM)
Monocular diffuser/cover that drives axial elongation in young mice.
Atropine
Muscarinic antagonist given here as 10 mg/mL eye drops three times daily.
CVI
Choroidal vascular index, a histologic proxy of choroidal microcirculation.
HIF-1α
Hypoxia-inducible factor-1α, upregulated in scleral hypoxia and reduced by atropine.
ECM remodeling
Scleral extracellular-matrix change (collagen volume fraction) that accompanies axial myopia.

Flashcards

1 / 8

Research intelligence for this paper

See its role on concept claims, tensions it is part of, placement history, and related discoveries.

Open paper intelligence

Quiz yourself

1 / 5

Mice per group numbered:

Common questions

How many mice per group?

N = 4 per group (four treatment arms).

What atropine regimen?

10 mg/mL drops three times daily.

What happened to axial length?

Atropine significantly reduced FDM axial elongation.

In-vitro hypoxia model?

Na2S2O4 on mouse scleral fibroblasts, then atropine.

More on Treatment adherence